Pharmacopsychiatry 2006; 39(3): 117-118
DOI: 10.1055/s-2006-941489
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Injectable Atypical Antipsychotics for Agitation in Borderline Personality Disorder

A Case ReportJ. C. Pascual1 , M. Madre1 , J. Soler1 , J. Barrachina1 , M. J. Campins1 , E. Alvarez1 , V. Pérez1
  • 1Department of Psychiatry, Sta. Creu and St. Pau Hospital, Barcelona, Spain, Universitat Autònoma de Barcelona
Further Information

Publication History

Received: 19.9.2005 Revised: 18.1.2006

Accepted: 13.2.2006

Publication Date:
23 May 2006 (online)

Zoom Image

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES).New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients.